Experiences with pre-travel diagnostic PCR testing for SARS-CoV-2: challenges and opportunities

Schneitler, Sophie; Gülker, Jana; Alhussein, Farah; Bub, Florian; Halfmann, Alexander; Klein, Lisa C.; Roth, Sophie; Jung, Philipp; Becker, Sören L.

doi:10.1093/jtm/taab116

Cited by 1 publication

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The yield of this approach may be relatively limited. One study of German travelers, conducted between October 2020 and January 2021, found positive pre-travel tests in only 0.58% of 521 international travelers [ 72 ]. A PCR test done 2–3 days before departure may still miss an infected traveler in the incubation period that will become infectious during travel or shortly after arrival at their destination.…”

Section: Covid-19 Mitigation and Control Measuresmentioning

confidence: 99%

Travel in the Time of COVID: A Review of International Travel Health in a Global Pandemic

Flaherty

Hamer

Chen

2022

Curr Infect Dis Rep

View full text Add to dashboard Cite

Purpose of Review This review critically considers the impact of the COVID-19 pandemic on global travel and the practice of travel medicine, highlights key innovations that have facilitated the resumption of travel, and anticipates how travel medicine providers should prepare for the future of international travel. Recent Findings Since asymptomatic transmission of the virus was first recognized in March 2020, extensive efforts have been made to characterize the pattern and dynamics of SARS-CoV-2 transmission aboard commercial aircraft, cruise ships, rail and bus transport, and in mass gatherings and quarantine facilities. Despite the negative impact of further waves of COVID-19 driven by the more transmissible Omicron variant, rapid increases of international tourist arrivals are occurring and modeling anticipates further growth. Mitigation of spread requires an integrated approach that combines masking, physical distancing, improving ventilation, testing, and quarantine. Vaccines and therapeutics have played a significant role in reopening society and accelerating the resumption of travel and further therapeutic innovation is likely. Summary COVID-19 is likely to persist as an endemic infection, and surveillance will assume an even more important role. The pandemic has provided an impetus to advance technology for telemedicine, to adopt mobile devices and GPS in contact tracing, and to apply digital applications in research. The future of travel medicine should continue to harness these novel platforms in the clinical, research, and educational arenas.

show abstract

Section: Covid-19 Mitigation and Control Measuresmentioning

confidence: 99%